Few women have heard of virus associated with genital warts (HPV) and its link with cervical cancerAugust 01, 2003Few women have heard of the virus associated with genital warts (HPV), or are aware that it is linked to cervical cancer, reveals a study in Sexually Transmitted Infections. The authors assessed women’s knowledge of human papillomavirus (HPV) by surveying those attending a Well Woman Clinic in central London. The survey took place over a period of 15 months from 2000 to 2002. In all, over 1000 women completed the survey during that time, amounting to around 80% of female clinic attenders invited to take part. The average age of the women was around 30 and they were mostly white, well educated, and in full time employment. Most said they had had between one and three sexual partners in the preceding 12 months.
Less than a third of the women had ever heard of papillomavirus, and those that had, tended to be older or had had an abnormal smear test result in the past. Knowledge about the virus was poor: fewer than half knew that the virus is the main cause of cervical cancer and only a third knew that genital warts, also caused by types of HPV, do not themselves cause the disease. Most believed that condoms protect against infection with the virus, although the evidence for this, say the authors, is not clear. But only half knew that the contraceptive pill does not protect against infection. Smokers were less likely to be well informed, a finding that is of some concern, say the authors, given that smoking increases the risk of cervical abnormalities and cancer among women infected with the virus. The authors venture that as the sample of women surveyed were well educated, it is likely that awareness of HPV among the general population is even lower. It is important to rectify this deficit so that women who participate in the cervical screening programme really understand the implications of their results, particularly if testing for the virus is to be introduced, as has been mooted, conclude the authors. British Medical Journal (BMJ) | |||||||||||||||||||||
|
Related Cervical Cancer Current Events and Cervical Cancer News Articles Social class dictates cancer risk Cervical and lung cancer are more common in poor people while rates of breast cancer and melanoma are higher in the wealthy. Model highlights benefits and risks of cervical cancer screening methods In an analysis based on a computer model, it appears that comparing the benefits and risks of different cervical cancer prevention approaches may help women and their physicians choose appropriate screening strategies. New HPV test for developing countries shows high accuracy in predicting cervical disease: Study A new HPV test developed by QIAGEN specifically for use in regions of the world with scarce resources is "substantially" more accurate in identifying women with cervical disease than the current methods (Pap testing and visual inspection) in these countries. As head and neck cancer risks evolve, more treatment options emerge Advances in understanding head and neck cancer over the last decade have led to more treatment options and improved quality of life for patients, according to a review published this week in the New England Journal of Medicine. Cervical cancer prevention should focus on vaccinating adolescent girls The cost-effectiveness of vaccination in the United States against human papillomavirus (HPV), a sexually-transmitted virus that causes cervical cancer, will be optimized by achieving universal vaccine coverage in young adolescent girls, by targeting initial "catch-up" efforts to vaccinate women younger than 21 years of age, and by revising current screening policies. Breaking the 'mucus barrier' with a new drug delivery system Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus - regarded by many as nearly impenetrable - and carrying medication that could treat a range of diseases. Those conditions include lung cancer, cervical cancer and cystic fibrosis, the research noted in a presentation scheduled for the 236th National Meeting of the American Chemical Society. Novel structure proteins could play a role in apoptosis Isoforms from Novel Structure Proteins (NSP), a new family of genes discovered by researchers in the Sbarro Institute for Cancer Research and Molecular Medicine in Temple University's College of Science and Technology, could be involved in apoptosis or programmed cell death. Obese women in Canada are less likely to be screened for cervical cancer Research in the United States has shown that obese people are less likely than their normal-weight peers to undergo screening for breast, colon and cervical cancer. Raj Padwal, Rebecca Mitchell and Scott Klarenbach, from the University of Alberta's Faculty of Medicine & Dentistry, have undertaken a study to see if this trend is also true in Canada. New study shows potential to treat or prevent viral cancers A new study, presented at the SNM 55th Annual Meeting, shows that radioimmunotherapy (RIT) targeting viral antigens offers a novel option to treat-or even prevent-many viral cancers by targeting cancer cells expressing viral antigens or infected cells before they convert into malignancy. Avoiding Spleen Removal for Cooley's Anemia Sufferers Researchers from Weill Cornell Medical College may have discovered the precise role of a gene in one of the world's most common blood disorders, beta-thalassemia, commonly known as Cooley's anemia. More Cervical Cancer Current Events and Cervical Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||